Belatacept in Renal Transplantation: Analyses Using Data From the Collaborative Transplant Study
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of Urelumab (BMS-663513) in Subjects With Advanced and/or Metastatic Solid Tumors and Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy Trial of Ipilimumab Versus Pemetrexed in Non-Squamous Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Short-term Adjuvant Therapy and Biomarker Studies With Targeted Agents in Women With Estrogen Receptor Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Korean Post-marketing Surveillance for Sprycel®
- Status
- COMPLETED
- Phase
- N/A
Comparison of Imatinib Versus Dasatinib in Patients With Newly-diagnosed Chronic Phase Chronic Myeloid Leukaemia
- Status
- COMPLETED
- Phase
- PHASE3
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1 Biomarker Study of Anti-PDL-1 in Advanced Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or Carcinosarcoma
- Status
- UNKNOWN
- Phase
- PHASE1
Study to Evaluate the Safety, Pharmacokinetics and Tolerability of BMS-708163
- Status
- COMPLETED
- Phase
- PHASE1
Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012)
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of Anti-Programmed Death-Ligand 1 in Hematologic Malignancy
- Status
- WITHDRAWN
- Phase
- PHASE1
Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone
- Status
- COMPLETED
- Phase
- PHASE3
Comparative Tolerability of Protease Inhibitors
- Status
- COMPLETED
- Phase
- N/A
Korean Post-marketing Surveillance for Reyataz®
- Status
- COMPLETED
- Phase
- N/A
Phase III BMS-790052 Add-On to Peg-Interferon Alfa-2a and Ribavirin in Naive Hepatitis C
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy Study of Pegylated Interferon Lambda Versus Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C
- Status
- WITHDRAWN
- Phase
- PHASE3
Safety Study of INX-08189, Pharmacokinetic and Pharmacodynamic With Ribavirin and Food Effect Study, in Chronically-infected Genotype 1 Hepatitis C Virus, Treatment-naïve Subjects
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2